• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Nutritional and Dietary Supplements Market in China - Demand for Herbal Supplements Product Image

Nutritional and Dietary Supplements Market in China - Demand for Herbal Supplements

  • Published: August 2011
  • Region: China
  • 38 Pages
  • Ken Research Private Limited

The health food industry is witnessing growth globally. A growing need to stay healthy and rising membership of gyms and health clubs is driving the demand for nutritional supplements across the world. Annually, China’s health food and products consumption amounts to USD 120 billion.

China is offering many opportunities and strong potential for the supplements industry, especially calcium and protein. The Chinese supplement industry is developing and the country offers good investment opportunities driven by the fast-paced economic growth, expanding upper middle class and increasing disposable income. Moreover, the industry is also seeing a rise in mergers/ acquisitions.

Rising income levels, urbanization, a growing interest in sports, along with a growing desire to stay healthy and obesity issues have been driving factors for the nutrient and supplement industry in China. The supplement industry in the region was even resilient in the phase of recession and showed a positive performance in 2010.

The report on “China Nutrition & Dietary Supplements Industry” includes a detailed study of the nutrition & supplements industry of the country. READ MORE >

1. China Nutrients and Dieteary Supplements Industry

1.1. Industry Overview

1.2. Market Size

1.2.1. By Segments

1.2.2. Scope for New Entrants

1.2.3. Whey Protien Demand
1.2.4. Sports Nutrition
1.2.5. Herbal Supplements
1.2.6. China Vitamin Demand
1.2.6.1 Vitamin E
1.2.6.2 Vitamin C

2. Industry Trends and Developments

2.1. Implication for Dietary Supplements Manufacturers
2.2. Invetsment Opportunities in China Supplement Industry
2.3. Deals, Mergers/ Acquisitions
2.4. Regulations
2.5. Issues in Approval for Chinese Herbal Medicines in the US
2.6. China to Set Restrictions on Investment in Vitamin C Sector

3. China Macro Economic Environment

3.1. GDP Recovery and Growth

3.2. Import/ Export

3.3. Population and Literacy Rate
3.3.1 Literacy Rate

4. Growth Drivers

4.1. Rapidly Aging Population

4.2. Disposable Income
4.3. Prevelance of Cardiovascular Disease

4.4. Focus on Weight Management

5. Company Profiles

5.1. North China Pharmaceutical Group Corporation (NCPC)
5.1.1. Company Overview
5.1.2. Financial Performance
5.1.3. Recent Developments

5.2. DSM
5.2.1. Company Overview

5.2.2. Financial Performance
5.2.3. Recent Developments
5.3. BASF
5.3.1. Company Overview

5.3.2. Financial Performance
5.3.3. Recent Developments

6. Appendix
6.1. Forecast Methodology

6.1.1. Data Collection Methods

6.1.2 Approach

6.1.3 Reasons for the Dependent and Independent Variables
6.1.4 Multi Factor Based Sensitivity Model
6.1.5 Regression Matrix
6.1.6 Final Conclusion
6.2. Abbreviations

6.3. Disclaimer

LIST OF FIGURES

Figure 1: Nutrition Supplements Purchase Behavior (2010)

Figure 2: China Nutritional and Dietary Supplements Market by Value (2003-2015F)
Figure 3: China Amino-based Nutritional Supplement Market (2003-2010)
Figure 4: Top Categories in Nutraceutical Industry in China by Value (2010)
Figure 5: Amino-based Nutritional Supplements Approved by SFDA (2003-2009)
Figure 6: China Herbal Supplements Demand by value (2003-2015F)
Figure 7: China Vitamin Market by Value (2003-2015F)

Figure 8: China Gross Domestic Product (2003-2010)
Figure 9: China GDP (Purchasing power parity) (2003-2010)

Figure 10: China Population (2003-2010)
Figure 11: China Literacy Rate (2003-2010)

Figure 12: China Urban per capita Disposable Income (2003-2010)

Figure 13: DSM Revenues by Business Segments in 2010

Figure 14: BASF Sales by First Customer Industry in 2010



LIST OF TABLES

Table 1: Import & Export Statistics (Jan to May 2011)

Table 2: Vitamin Import Data in China in January 2010
Table 3: BASF Financials (2009&2010)

Table 4: BASF Financials by Business Segments (2009&2010)
Table 5: Dependent & Independent Variables (2003-2010)
Table 6: Correlation Matrix

Table 7: Regression Coefficients output

- North China Pharmaceutical group Corporation (NCPC)
- DSM
- BASF

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos